Market Segmentation
Coronary stents Product Outlook (USD Billion, 2018-2032)
·        Drug Eluting Stents
·        Bare Metal StentsÂ
·        Biosorbable Vascular Scaffolds
Coronary stents End-Users Outlook (USD Billion, 2018-2032)
·        Hospitals and Clinics
·        Ambulatory Surgical Center
·        Specialty Center
·        Others
Coronary stents Regional Outlook (USD Billion, 2018-2032)
·        North America Outlook (USD Billion, 2018-2032)
o  North America Coronary stents by Product
§ Drug Eluting Stents
§ Bare Metal Stents
§ Biosorbable Vascular Scaffolds
o  North America Coronary stents by End-User
§ Hospitals and Clinics
§ Ambulatory Surgical Center
§ Specialty Center
§ Others
o  USOutlook (USD Billion, 2018-2032)
o  US Coronary stents by Product
§ Drug Eluting Stents
§ Bare Metal Stents
§ Biosorbable Vascular Scaffolds
o  US Coronary stents by End-User
§ Hospitals and Clinics
§ Ambulatory Surgical Center
§ Specialty Center
§ Others
o  CANADA Outlook (USD Billion, 2018-2032)
o  CANADA Coronary stents by Product
§ Drug Eluting Stents
§ Bare Metal Stents
§ Biosorbable Vascular Scaffolds
o  CANADA Coronary stents by End-User
§ Hospitals and Clinics
§ Ambulatory Surgical Center
§ Specialty Center
§ Others
·        EuropeOutlook (USD Billion, 2018-2032)
o  EUROPE Coronary stents by Product
§ Drug Eluting Stents
§ Bare Metal Stents
§ Biosorbable Vascular Scaffolds
o  EUROPE Coronary stents by End-User
§ Hospitals and Clinics
§ Ambulatory Surgical Center
§ Specialty Center
§ Others
o  Germany Outlook (USD Billion, 2018-2032)
o  Germany Coronary stents by Product
§ Drug Eluting Stents
§ Bare Metal Stents
§ Biosorbable Vascular Scaffolds
o  Germany Coronary stents by End-User
§ Hospitals and Clinics
§ Ambulatory Surgical Center
§ Specialty Center
§ Others
o  France Outlook (USD Billion, 2018-2032)
o  France Coronary stents by Product
§ Drug Eluting Stents
§ Bare Metal Stents
§ Biosorbable Vascular Scaffolds
o  France Coronary stents by End-User
§ Hospitals and Clinics
§ Ambulatory Surgical Center
§ Specialty Center
§ Others
o  UK Outlook (USD Billion, 2018-2032)
o  UK Coronary stents by Product
§ Drug Eluting Stents
§ Bare Metal Stents
§ Biosorbable Vascular Scaffolds
o  UK Coronary stents by End-User
§ Hospitals and Clinics
§ Ambulatory Surgical Center
§ Specialty Center
§ Others
o  ITALY Outlook (USD Billion, 2018-2032)
o  ITALY Coronary stents by Product
§ Drug Eluting Stents
§ Bare Metal Stents
§ Biosorbable Vascular Scaffolds
o  ITALY Coronary stents by End-User
§ Hospitals and Clinics
§ Ambulatory Surgical Center
§ Specialty Center
§ Others
o  SPAIN Outlook (USD Billion, 2018-2032)
o  Spain Coronary stents by Product
§ Drug Eluting Stents
§ Bare Metal Stents
§ Biosorbable Vascular Scaffolds
o  Spain Coronary stents by End-User
§ Hospitals and Clinics
§ Ambulatory Surgical Center
§ Specialty Center
§ Others
o  Rest Of Europe Outlook (USD Billion, 2018-2032)
o  Rest of Europe Coronary stents by Product
§ Drug Eluting Stents
§ Bare Metal Stents
§ Biosorbable Vascular Scaffolds
o  Rest of Europe Coronary stents by End-User
§ Hospitals and Clinics
§ Ambulatory Surgical Center
§ Specialty Center
§ Others
·        Asia-Pacific Outlook (USD Billion, 2018-2032)
o  Asia-Pacific Coronary stents by Product
§ Drug Eluting Stents
§ Bare Metal Stents
§ Biosorbable Vascular Scaffolds
o  Asia-Pacific Coronary stents by End-User
§ Hospitals and Clinics
§ Ambulatory Surgical Center
§ Specialty Center
§ Others
o  China Outlook (USD Billion, 2018-2032)
o  China Coronary stents by Product
§ Drug Eluting Stents
§ Bare Metal Stents
§ Biosorbable Vascular Scaffolds
o  China Coronary stents by End-User
§ Hospitals and Clinics
§ Ambulatory Surgical Center
§ Specialty Center
§ Others
o  Japan Outlook (USD Billion, 2018-2032)
o  Japan Coronary stents by Product
§ Drug Eluting Stents
§ Bare Metal Stents
§ Biosorbable Vascular Scaffolds
o  Japan Coronary stents by End-User
§ Hospitals and Clinics
§ Ambulatory Surgical Center
§ Specialty Center
§ Others
o  India Outlook (USD Billion, 2018-2032)
o  India Coronary stents by Product
§ Drug Eluting Stents
§ Bare Metal Stents
§ Biosorbable Vascular Scaffolds
o  India Coronary stents by End-User
§ Hospitals and Clinics
§ Ambulatory Surgical Center
§ Specialty Center
§ Others
o  Australia Outlook (USD Billion, 2018-2032)
o  Australia Coronary stents by Product
§ Drug Eluting Stents
§ Bare Metal Stents
§ Biosorbable Vascular Scaffolds
o  Australia Coronary stents by End-User
§ Hospitals and Clinics
§ Ambulatory Surgical Center
§ Specialty Center
§ Others
o  Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)
o  Rest of Asia-Pacific Coronary stents by Product
§ Drug Eluting Stents
§ Bare Metal Stents
§ Biosorbable Vascular Scaffolds
o  Rest of Asia-Pacific Coronary stents by End-User
§ Hospitals and Clinics
§ Ambulatory Surgical Center
§ Specialty Center
§ Others
·        Rest of the World Outlook (USD Billion, 2018-2032)
o  Rest of the World Coronary stents by Product
§ Drug Eluting Stents
§ Bare Metal Stents
§ Biosorbable Vascular Scaffolds
o  Rest of the World Coronary stents by End-User
§ Hospitals and Clinics
§ Ambulatory Surgical Center
§ Specialty Center
§ Others
o  Middle East Outlook (USD Billion, 2018-2032)
o  Middle East Coronary stents by Product
§ Drug Eluting Stents
§ Bare Metal Stents
§ Biosorbable Vascular Scaffolds
o  Middle East Coronary stents by End-User
§ Hospitals and Clinics
§ Ambulatory Surgical Center
§ Specialty Center
§ Others
o  Africa Outlook (USD Billion, 2018-2032)
o  Africa Coronary stents by Product
§ Drug Eluting Stents
§ Bare Metal Stents
§ Biosorbable Vascular Scaffolds
o  Africa Coronary stents by End-User
§ Hospitals and Clinics
§ Ambulatory Surgical Center
§ Specialty Center
§ Others
o  Latin America Outlook (USD Billion, 2018-2032)
o  Latin America Coronary stents by Product
§ Drug Eluting Stents
§ Bare Metal Stents
§ Biosorbable Vascular Scaffolds
o  Latin America Coronary stents by End-User
§ Hospitals and Clinics
§ Ambulatory Surgical Center
§ Specialty Center
§ Others
Table of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Coronary Stents Market, by Products
6.1 Introduction
6.2 Drug Eluting Stents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3 Bare Metal Stents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4 Bioresorbable Vascular Scaffolds
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 7. Global Coronary Stents Market, By End-User
7.1 Introduction
7.2 Hospitals and Clinics
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3 Ambulatory Surgical Centers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4 Specialty Centers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.5 Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 8. Global Coronary Stents Market, by Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 US
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 Italy
8.3.1.4 Spain
8.3.1.5 UK
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Middle East
8.5.2 Africa
Chapter 9. Company Landscape
9.1 Introduction
9.2 Market Share Analysis
9.3 Key Development & Strategies
Chapter 10. Company Profiles
10.1 Abbott
10.1.1 Company Overview
10.1.2 Product Overview
10.1.3 Financials Overview
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 B. Braun Melsungen AG
10.2.1 Company Overview
10.2.2 Product Overview
10.2.3 Financial Overview
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 Biotronik SE & Co. KG
10.3.1 Company Overview
10.3.2 Product Overview
10.3.3 Financial Overview
10.3.4 Key Development
10.3.5 SWOT Analysis
10.4 Boston Scientific Corporation
10.4.1 Company Overview
10.4.2 Product Overview
10.4.3 Financial Overview
10.4.4 Key Development
10.4.5 SWOT Analysis
10.5 C. R. Bard, Inc.
10.5.1 Company Overview
10.5.2 Product Overview
10.5.3 Financial overview
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.6 Cook Medical
10.6.1 Company Overview
10.6.2 Product Overview
10.6.3 Financial Overview
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.7 Elixir Medical Corporation
10.7.1 Overview
10.7.2 Product Overview
10.7.3 Financial Overview
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.8 Medtronic plc
10.8.1 Overview
10.8.2 Product Overview
10.8.3 Financials
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.9 Meril Life Sciences
10.9.1 Overview
10.9.2 Product Overview
10.9.3 Financials
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.10 MicroPort Scientific Corporation
10.10.1 Overview
10.10.2 Product Overview
10.10.3 Financials
10.10.4 Key Developments
10.10.5 SWOT Analysis
10.11 Stentys SA
10.11.1 Overview
10.11.2 Product Overview
10.11.3 Financials
10.11.4 Key Developments
10.11.5 SWOT Analysis
10.10 Terumo Corporation
10.10.1 Overview
10.10.2 Product Overview
10.10.3 Financials
10.10.4 Key Developments
10.10.5 SWOT Analysis
Chapter 11 MRFR Conclusion
11.1 Key Findings
11.1.1 From CEO’s View point
11.1.2 Unmet Needs of the Market
11.2 Key Companies to Watch
11.3 Predictions for the Coronary Stents Market Industry
Chapter 12. Appendix
LIST OF TABLES
Table 1 Global Coronary Stents Market Synopsis, 2020-2027
Table 2 Global Coronary Stents Market Estimates and Forecast, 2020-2027 (USD Million)
Table 3 Global Coronary Stents Market, by Product, 2020-2027 (USD Million)
Table 4 Global Coronary Stents Market, by End-User, 2020-2027 (USD Million)
Table 5 Global Coronary Stents Market, by Region, 2020-2027(USD Million)
Table 6 North America: Coronary Stents Market, by Product, 2020-2027 (USD Million)
Table 7 North America: Coronary Stents Market, by End-User, 2020-2027 (USD Million)
Table 8 North America: Coronary Stents Market, by Region, 2020-2027 (USD Million)
Table 9 US: Coronary Stents Market, by Product, 2020-2027 (USD Million)
Table 10 US: Coronary Stents Market, by End-User, 2020-2027 (USD Million)
Table 11 US: Coronary Stents Market, by Region, 2020-2027 (USD Million)
Table 12 Canada: Coronary Stents Market, by Product, 2020-2027 (USD Million)
Table 13 Canada: Coronary Stents Market, by End-User, 2020-2027 (USD Million)
Table 14 Canada: Coronary Stents Market, by Region, 2020-2027 (USD Million)
Table 15 South America: Coronary Stents Market, by Product, 2020-2027 (USD Million)
Table 16 South America: Coronary Stents Market, by End-User, 2020-2027 (USD Million)
Table 17 South America: Coronary Stents Market, by Region, 2020-2027 (USD Million)
Table 18 Europe: Coronary Stents Market, by Product, 2020-2027 (USD Million)
Table 19 Europe: Coronary Stents Market, by End-User, 2020-2027 (USD Million)
Table 20 Europe: Coronary Stents Market, by Region, 2020-2027 (USD Million)
Table 21 Western Europe: Coronary Stents Market, by Product, 2020-2027 (USD Million)
Table 22 Western Europe: Coronary Stents Market, by End-User, 2020-2027 (USD Million)
Table 23 Western Europe: Coronary Stents Market, by Region, 2020-2027 (USD Million)
Table 24 Eastern Europe: Coronary Stents Market, by Product, 2020-2027 (USD Million)
Table 25 Eastern Europe: Coronary Stents Market, by End-User, 2020-2027 (USD Million)
Table 26 Eastern Europe: Coronary Stents Market, by Region, 2020-2027 (USD Million)
Table 27 Asia-Pacific: Coronary Stents Market, by Product, 2020-2027 (USD Million)
Table 28 Asia-Pacific: Coronary Stents Market, by End-User, 2020-2027 (USD Million)
Table 29 Asia-Pacific: Coronary Stents Market, by Region, 2020-2027 (USD Million)
Table 30 Middle East & Africa: Coronary Stents Market, by Product, 2020-2027 (USD Million)
Table 31 Middle East & Africa: Coronary Stents Market, by End-User, 2020-2027 (USD Million)
Table 32 Middle East & Africa: Coronary Stents Market, by Region, 2020-2027 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Coronary Stents Market
Figure 3 Segmentation Market Dynamics for Global Coronary Stents Market
Figure 4 Global Coronary Stents Market Share, by Product, 2020 (%)
Figure 5 Global Coronary Stents Market Share, by End-User, 2020 (%)
Figure 6 Global Coronary Stents Market Share, by Region, 2020 (%)
Figure 7 North America: Coronary Stents Market Share, by Country, 2020 (%)
Figure 8 Europe: Coronary Stents Market Share, by Country, 2020 (%)
Figure 9 Asia-Pacific: Coronary Stents Market Share, by Country, 2020 (%)
Figure 10 Middle East & Africa: Coronary Stents Market Share, by Country, 2020 (%)
Figure 11 Global Coronary Stents Market: Company Share Analysis, 2020 (%)
Figure 12 Abbott: Key Financials
Figure 13 Abbott: Segmental Revenue
Figure 14 Abbott: Geographical Revenue
Figure 15 B. Braun Melsungen AG: Key Financials
Figure 16 B. Braun Melsungen AG: Segmental Revenue
Figure 17 B. Braun Melsungen AG: Geographical Revenue
Figure 18 Biotronik SE & Co. KG: Key Financials
Figure 19 Biotronik SE & Co. KG: Segmental Revenue
Figure 20 Biotronik SE & Co. KG: Geographical Revenue
Figure 21 Boston Scientific Corporation: Key Financials
Figure 22 Boston Scientific Corporation: Segmental Revenue
Figure 23 Boston Scientific Corporation: Geographical Revenue
Figure 24 C. R. BARD, INC.: Key Financials
Figure 25 C. R. BARD, INC.: Segmental Revenue
Figure 26 C. R. BARD, INC.: Geographical Revenue
Figure 27 Cook Medical: Key Financials
Figure 28 Cook Medical: Segmental Revenue
Figure 29 Cook Medical: Geographical Revenue
Figure 30 Elixir Medical Corporation: Key Financials
Figure 31 Elixir Medical Corporation: Segmental Revenue
Figure 32 Elixir Medical Corporation: Geographical Revenue
Figure 33 Medtronic plc: Key Financials
Figure 34 Medtronic plc: Segmental Revenue
Figure 35 Medtronic plc: Geographical Revenue
Figure 36 Meril Life Sciences: Key Financials
Figure 37 Meril Life Sciences: Segmental Revenue
Figure 38 Meril Life Sciences: Geographical Revenue
Figure 39 MicroPort Scientific Corporation: Key Financials
Figure 40 MicroPort Scientific Corporation: Segmental Revenue
Figure 41 MicroPort Scientific Corporation: Geographical Revenue
Figure 42 Stentys SA: Key Financials
Figure 43 Stentys SA: Segmental Revenue
Figure 44 Stentys SA: Geographical Revenue
Figure 45 Terumo Corporation: Key Financials
Figure 46 Terumo Corporation: Segmental Revenue
Figure 47 Terumo Corporation: Geographical Revenue
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
